GlycoMimetics awards retention bonuses to CFO, CBO, CSO; induces plan shares to 3M

CRESCENT BIOPHARMA, INC.

CFO Brian Hahn and CBO Armand Girard eligible for retention bonus up to 60% of base salary; CSO John Magnani up to 20%.
40% of bonus payable Aug 1, 2022; remaining 60% payable Aug 1, 2023, contingent on continued employment through each date.
Inducement Plan share reserve increased from 2M to 3M shares to support equity awards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.